# Thiotepa

NDC: 25021-246
Generic name: Thiotepa
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Marketing started: 20180615

FDA application: ANDA209150

## Active ingredients

- THIOTEPA: 15 mg/1.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-246"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-246
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=448c29f1-6d9c-4f8e-8a69-9b85e973e728